US EditionBMRN FY2025 EPS Forecast Boosted by Cantor Fitzgerald
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
BMRN FY2025 EPS Forecast Boosted by Cantor Fitzgerald
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for shares of BioMarin Pharmaceutical in a research report issued to clients and investors on Friday, May 2nd. Cantor Fitzgerald analyst O. Brayer now anticipates that the biotechnology company will earn $3.61 per share for the year, […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
